Trust Company of Vermont’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$4.93K Hold
20
﹤0.01% 942
2025
Q3
$3.53K Hold
20
﹤0.01% 965
2025
Q2
$2.75K Hold
20
﹤0.01% 980
2025
Q1
$3.61K Hold
20
﹤0.01% 890
2024
Q4
$3.13K Buy
+20
New +$3.55K ﹤0.01% 913

Other funds holding KRYS

Trust Company of Vermont's KRYS Position: Q4 2025 in Review

Trust Company of Vermont held its Krystal Biotech (KRYS) position steady in Q4 2025 at 20 shares worth $4.93K. The position accounts for ﹤0.01% of the portfolio, ranked #942.

Trust Company of Vermont first reported a position in KRYS in Q4 2024 and has held it in 5 quarters since. 334 funds tracked by Wall St. Rank hold KRYS as of Q4 2025.

  • Trust Company of Vermont held 20 shares of Krystal Biotech worth $4.93K as of Q4 2025.
  • Trust Company of Vermont left its Krystal Biotech share count unchanged in Q4 2025.
  • Krystal Biotech made up ﹤0.01% of Trust Company of Vermont's portfolio in Q4 2025, its #942 holding.
  • Trust Company of Vermont first reported a position in Krystal Biotech in Q4 2024 and has held it in 5 quarters since.
  • 334 funds tracked by Wall St. Rank held Krystal Biotech as of Q4 2025.

Based on Trust Company of Vermont's 13F filing for Q4 2025, filed 16 Jan 2026.